#standortklausel

1 story

#drug pricing #germany #healthcare regulation #innovation policy #manufacturer discounts #pharmaceutical industry #politics #roche pharma ag #world

Germany must turn pharma promises into law
Roche argues Germany's conflicting signals on drug innovation are driving investment and research elsewhere, threatening medical supply and sovereignty.
POLITICO · 2m